Heterologous production and purification of PhhA and PhhA single point mutants
The phhA gene (encoding Phe3H) was PCR-amplified from Streptomyces coeruleorubidus AB1183F64 using The purity was assessed by SDS-PAGE analysis ( Figure S1 ). Protein concentrations were determined by the Bradford method using BSA as the standard. To determine metal stoichiometry, protein concentrations were determined by amino acid analysis (PNAC facility, Department of Biochemistry, University of Cambridge, UK); metal analysis was performed on a Varian Vista-PRO ICP-OES at the School of Environmental Sciences, University of East Anglia, UK or by ICP-MS at the University of Edinburgh.
Site directed mutagenesis for production of PhhA single point mutants
Site-directed mutagenesis was accomplished by a modified QuickChange method using primers bearing desired mutations. The PCR contained 1X HF buffer (ThermoScientific), 2.5 mM dNTPs, 5% v/v DMSO, 1-10 ng template DNA, 250 nM of each primer, 0.5 μL Phusion HiFi DNA polymerase (New England Biolabs) and
MilliQ water to a final volume of 50 μL. PCR was carried out using the following parameters: 98 °C for 30 seconds, then 20 cycles of 98 °C for 15 seconds, 60 °C for 45 seconds and 72 °C for 6 minutes, then 10 minutes at 72 °C. PCR reactions were then treated with Dpn1 and 5 μL of the resultant mixture was used to transform 100 μL DH10B-T1 competent cells. Plasmid DNA was isolated by MiniPrep (Qiagen) and the gene of interest verified by Sanger sequencing using T7 forward and T7 reverse primers. Protein expression was carried out using E. coli BL21 (DE3) as the host strain as described for above.
Enzyme assays

Optimisation of Phe3H assay conditions
Prior to measuring the Michaelis-Menten kinetics of Phe3H, we sought to optimise the assay conditions and identify potential inhibitors of the enzyme. Phe3H was expressed heterologously in E. coli and purified by Niaffinity and size exclusion chromatography ( Figure S1 ). The resultant enzyme was screened for activity in MES, HEPES and Tris buffers across their pH ranges. In contrast to previously reported data, 1 only baseline levels of activity were detected below pH 7, with the optimal tested conditions being HEPES buffer at pH 8. Swapping
to Tris buffer at pH 8 resulted in a 2.5-fold decrease in enzyme activity ( Figure S2 ). This result has also been reported for rat and bovine PhhA, in which it was proposed that Tris may coordinate directly to the active ferric iron centre, thereby decreasing the rate of Fe(III) reduction. 2,3
The influence of additives such as ascorbate, excess ferrous iron, catalase and superoxide dismutase (SOD) was also investigated. SOD and catalase were found to rescue the activity of Phe3H in the presence of excess Fe(II) and protect the tetrahydropterin cofactor from non-enzymatic oxidation, further improving the efficiency of this reaction ( Figures S3-S5 ). Ascorbate and dithiothreitol (DTT) were also found to slow down the non-enzymatic oxidation of the pterin cofactor. As DTT can scavenge Fe(II) from the active site of the enzyme, however, it was omitted from the enzymatic assays. 3-5
Substrate scope experiments
The assay mixture contained Phe3H (5 µM), amino acid (1 mM), catalase (10 U µL -1 ), and SOD (0.1 U µL -1 )
in 40 mM HEPES, pH 8.0. Reactions (in duplicate) were started by addition of 6MPH 4 (1 mM) and incubated at 28 °C for 3 h. Enzyme was removed by ultrafiltration using VWR centrifugal filters (modified PES membrane, MWCO 10 kDa). The flow-through was analysed by UPLC as described below and by LC-MS.
Phe3H reaction mixtures for kinetic analysis were carried out at least in triplicate and contained 0.5 µM Phe3H, 0.5 mM 6MPH 4 or DMPH 4 , 1 U µL -1 catalase, 0.01 U µL -1 superoxide dismutase and varying amounts of L-Phe (or [3,5-d 2 ]-L-Phe, 2F-DL-Phe or 4F-DL-Phe) in 40 mM HEPES, pH 8.0. Alternatively, the L-Phe concentration was kept constant (5 mM) and the concentration of 6MPH 4 or DMPH 4 was varied. Reactions were started by the addition of 6MPH 4 or DMPH 4 after preincubation at 28 °C for 6 -8 min. Reactions were carried out at 28 °C and were quenched after 3 min with an equal volume of 1% trifluoroacetic acid. IC 50 s for metal and DL-3F-Phe inhibition were determined using the same conditions as for kinetic analysis using 6MPH 4 as cofactor with the addition of the indicated metal ions (0.001 µM -1 mM) at a fixed L-Phe concentration (5 mM Tyr was used as standard, whereas for quantitation of fluorinated mTyr, compounds were purified from enzyme reactions and quantified by qNMR using maleic acid as standard.
Kinetic analyses and inhibitor studies 1
Non-linear regression was performed using Prism software. For steady-state kinetics the data points (4 -6
where v 0 is the initial rate (µM product min -1 ), V max is the maximal reaction velocity, K M is the Michaelis-Menten constant. The rate constant k cat was calculated as V max / [Phe3H].
The associated error in k cat and K M values were calculated using the following equation 6, 7 :
For steady state kinetics with substrate inhibition, data were fitted to * * Eq. 3
where K i is the inhibitor binding constant for reversible inhibitors.
For inhibition by DL-3F-Phe, the measured rates were presented as Lineweaver-Burk plots for each inhibitor concentration. Slopes were determined by linear regression and plotted against the inhibitor concentration to
give the secondary plot. Linear regression was used to determine the X axis intercept x y=0 , with the IC 50 = -x y=0 . 6
pH dependence
Potassium phosphate buffers were prepared at 100 mM for pH 5.8, 6.3, 6.6, 7.0, 7.5, 7.9, 8.5, and were used at 50 mM final concentration. Reactions contained 0.5 µM Phe3H, 5 mM L-Phe, and were started by the addition of 0.1 mM DMPH 4 after preincubation at 28 °C for 5-7 minutes. Reactions were conducted in triplicate with 100 µL reaction volume in 96-well plates (Nunc). The formation of mTyr was monitored by measuring the change in fluorescence at  em 305 nm ( ex 270 nm) using a Molecular Devices SpectraMax® M5 instrument. In an independent experiment, MES, HEPES and Tris buffers were prepared to 60 mM ionic strength (calculated using the Buffer Calculator tool on www.biomol.net) to give pH 6.2 and 6.8 (106 mM or 72 mM MES, respectively), pH 6.8, 7.4, and 8.0 (385 mM, 142 mM, and 81 mM HEPES, respectively), pH 8.0, 8.4, and 8.8
(100 mM, 160 mM, and 310 mM Tris, respectively). The final ionic strength in the reactions was 30 mM for each buffer. Enzyme reactions were conducted in triplicate at 28 °C and contained 0.5 µM Phe3H, 1 mM ascorbate, 1 mM L-Phe. The reactions were preincubated for 5-10 minutes, started by addition of 0.5 mM 6MPH 4 and stopped after 5 min by addition of an equal volume of 1% aq. TFA. Reactions were analysed by UPLC (Waters Acquity UPLC® BEH C18 column) as described in the above.
Non-enzymatic oxidation of pterin co-factor
Reactions were conducted in duplicate at 28 °C in Nunc 96-well plates with a 200 µL reaction volume. The oxidation of DMPH 4 to DMPH 2 was monitored by recording the increase in absorbance at 340 nm using a phenylalanine only the L-reagent was used. HRMS analysis of pure compounds was provided by the EPSRC National Mass Spectrometry Facility (Swansea, UK) or performed in-house on the above instrument. The mass error (ppm) and the relative peak intensity (%) are indicated. Hz), 19.6. HRMS (APCI, +ve) calculated for C 7 H 8 D 2 N (M+H + ) 110. 0933, found 110.0930 (-3.0 ppm).
LC-HRMS and HRMS analysis
NMR analysis
[3,5-d 2 ]-Toluene
The method described by Fries and Imbert was adapted as follows. 7 To an aqueous HCl solution (1 N, 35 mL) was added [2,6-d 2 ]-para-toluidine (9.3 g, 62.6 mmol, 1 eq.), and the mixture was heated to 70 °C for 10 minutes.
The solution was then cooled to 0 °C and sodium nitrite (5.15 g, 74.6 mmol, 1.2 eq., in 25 mL distilled water) 
[3,5-d 2 ]-Benzaldehyde
The procedure was adapted from Zhao. 8 A solution of cerium(IV) ammonium nitrate (35 g, 64 mmol, 2 eq.) in 3.5 M nitric acid (130 mL) was added to [3,5-d 2 ]-toluene (3.0 g, 32 mmol, 1 eq.) and the orange solution was heated to 80 °C for 2 hours. The yellow solution was cooled to room temperature, then diethylether (100 mL) was added and the organic phase was washed with distilled water until the aqueous layer was pH 7. The organic layer was dried (MgSO 4 ) and the solvent carefully removed in vacuo. This procedure was repeated and the crude benzaldehyde extracts were combined. Distillation afforded the title compound as a yellow liquid that contained 0.5 eq. starting material. The corrected yield was 12% (1.31 g, 8 mmol). 1 
[3,5-d 2 ]-Phenylpyruvic acid
The procedure was adapted from patent literature. 9,10 In two 1 mL reaction vials was assembled each: hydantoin (250 mg, 2.5 mmol, 1.4 eq.), [3,5-d 2 ]-benzaldehyde (260 mg containing 0.5 eq [3,5-d 2 ]-toluene, 1.8 mmol, 1 eq.), ethanolamine (15 µL, 0.25 mmol, 0.1 eq.), and 0.6 mL MQ-water. The vials were sealed, immersed in mineral oil and heated to 110 °C. The suspension initially dissolved upon heating of the mixture; after 5 hours at 110 °C, [3,5-d 2 ]-benzylidenehydantoin precipitated and the mixture was allowed to cool to room temperature.
The suspension from both reaction vials was combined in a 50 mL round-bottom flask, the vials rinsed with MW-water (1 mL) and an aqueous NaOH solution (5 mL of a 5 N solution, 25 mmol NaOH, 7 eq.) was added.
The reaction was heated to reflux under nitrogen atmosphere for 90 minutes The resulting solution was cooled to 20 °C and the pH carefully adjusted to 8.5 with concentrated aqueous HCl solution. NaCl (1.5 g) was added to aid precipitation and the mixture was left standing overnight. The solids were collected in a scintered funnel, washed with ice cold distilled water (3 mL) and methanol (3 mL). The filter cake was redissolved in distilled water and freeze-dried to give [3, 5- 
[3,5-d 2 ]-L-Phenylalanine
The procedure from Raap et al. was used. 11 The reaction was carried out in ammonium formate buffer (1 M, 168.0983 (-3.0 ppm, 100.0%).
Enzyme reactions
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